Serum profile of pro- and anti-inflammatory cytokines in rats following implantation of low-temperature plasma-modified titanium plates

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 5, 2012, Pages 1299-1307

  Walschus, Uwe ^a   Hoene, Andreas ^a   Patrzyk, MacIej ^a   Finke, Birgit ^b   Polak, Martin ^b   Lucke, Silke ^a   Nebe, Barbara ^c   Schroeder, Karsten ^b   Podbielski, Andreas ^c   Wilhelm, Lutz ^d   Schlosser, Michael ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b LEIBNIZ INSTITUTE FOR PLASMA SCIENCE AND TECHNOLOGY   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d Hospital Demmin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACIDS; ALLYL AMINE; ANTI-INFLAMMATORIES; CELL-MATERIAL INTERACTION; CORRELATION ANALYSIS; CYTOKINES; INFLAMMATORY CELLS; INFLAMMATORY RESPONSE; INTRAMUSCULAR IMPLANTATION; LOW TEMPERATURE PLASMAS; LOW TEMPERATURES; PLASMA MODIFICATIONS; TITANIUM PLATE;

BODY FLUIDS; CARBOXYLIC ACIDS; CELL CULTURE; CELL PROLIFERATION; ORGANIC POLYMERS; TITANIUM;

PLASMAS;

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TITANIUM; TITANIUM PLASMA POLYMERIZED ACRYLIC ACID; TITANIUM PLASMA POLYMERIZED ALLYL AMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL POPULATION; CONTROLLED STUDY; IMPLANT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CURING LIGHTS, DENTAL; CYTOKINES; EQUIPMENT AND SUPPLIES; INFLAMMATION MEDIATORS; MALE; METABOLOME; PLASMA GASES; PROSTHESIS IMPLANTATION; RATS; RATS, INBRED LEW; SURFACE PROPERTIES; TITANIUM;

RATTUS;

EID: 84863315861     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4600-z     Document Type: Article

References (45)

1. Esposito M. Titanium for dental applications. In: Brunette DM, Tengvall P, Textor M, Thomsen P, editors. Titanium in medicine. Berlin: Springer; 2001. p. 172-230.
2. Finke B, Lüthen F, Schröder K, Mueller PD, Bergemann C, Frant M, Ohl A, Nebe BJ. Positively charged plasma polymerized titanium boosts osteoblastic focal contact formation in the initial adhesion phase. Biomaterials. 2007;28:4521-34. (Pubitemid 47225112)
3. Schröder K, Finke B, Ohl A, Lüthen F, Bergemann C, Nebe B, Rychly J, Walschus U, Schlosser M, Liefeith K, Neumann HG, Weltmann KD. Capability of differently charged plasma polymer coatings for control of tissue interactions with titanium surfaces. J Adhes Sci Technol. 2010;24:1191-205.
4. Xia Z, Triffitt T. A review on macrophage responses to biomaterials. Biomed Mater. 2006;1:R1-9.
5. Davis C, Fischer J, Ley K, Sarembock IJ. The role of inflammation in vascular injury and repair. J Thromb Haemost. 2003;1:1699-709.
6. Rodriguez A, Voskerician G, Meyerson H, Macewan SR, Anderson JM. T cell subset distributions following primary and secondary implantation at subcutaneous biomaterial implant sites. J Biomed Mater Res A. 2008;85:556-65. (Pubitemid 351535338)
7. Goodman SB. Wear particles, periprosthetic osteolysis and the immune system. Biomaterials. 2007;28:5044-8. (Pubitemid 47488481)
8. Wang C, Lennartz MR, Loegering DJ, Stenken JA. Multiplexed cytokine detection of interstitial fluid collected from polymeric hollow tube implants - a feasibility study. Cytokine. 2008;43: 15-9.
9. Schutte RJ, Xie L, Klitzman B, Reichert WM. In vivo cytokineassociated responses to biomaterials. Biomaterials. 2009;30: 160-8.
10. Rodriguez A, Meyerson H, Anderson JM. Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. J Biomed Mater Res A. 2009;89:152-9.
11. Pereira-Lucena CG, Artigiani-Neto R, Lopes-Filho GJ, Frazao CV, Goldenberg A, Matos D, Linhares MM. Experimental study comparing meshes made of polypropylene, polypropylene ? polyglactin and polypropylene ? titanium: inflammatory cytokines, histological changes and morphometric analysis of collagen. Hernia. 2010;14:299-304.
12. Gallo J, Mrazek F, Petrek M. Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study. BMC Med Genet. 2009;10:109.
13. Smith KA. IL-2. In: Oppenheim JJ, Feldmann M, editors. Cytokine reference: a compendium of cytokines and other mediators of host defense. San Diego: Academic Press; 2001. p. 113-25.
14. Billiau A, Vandenbroeck K. IFNc. In: Oppenheim JJ, Feldmann M, editors. Cytokine reference: a compendium of cytokines and other mediators of host defense. San Diego: Academic Press; 2001. p. 641-88.
15. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Ann Rev Immunol. 2009;27:451-83.
16. Billiau A, Matthys P. Interferon-c: a historical perspective. Cytokine Growth Factor Rev. 2009;20:97-113.
17. Matsuda T, Hirano T. IL-6. In: Oppenheim JJ, Feldmann M, editors. Cytokine reference: a compendium of cytokines and other mediators of host defense. San Diego: Academic Press; 2001. p. 537-63.
18. Keegan AD. IL-4. In: Oppenheim JJ, Feldmann M, editors. Cytokine reference: a compendium of cytokines and other mediators of host defense. San Diego: Academic Press; 2001. p. 127-35.
19. RdW Malefyt. IL-10. In: Oppenheim JJ, Feldmann M, editors. Cytokine reference: a compendium of cytokines and other mediators of host defense. San Diego: Academic Press; 2001. p. 165-85.
20. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205-18.
21. Kou PM, Babensee JE. Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. J Biomed Mater Res A. 2011;96:239-60.
22. McKenzie ANJ, Matthews DJ. IL-13. In: Oppenheim JJ, Feldmann M, editors. Cytokine reference: a compendium of cytokines and other mediators of host defense. San Diego: Academic Press; 2001. p. 203-11.
23. Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21:425-56. (Pubitemid 37174537)
24. Finke B, Schröder K, Ohl A. Structure retention and water stability of microwave plasma polymerized films from allylamine and acrylic acid. Plasma Process Polym. 2009;6:S70-4.
25. Hoene A, Walschus U, Patrzyk M, Finke B, Lucke S, Nebe B, Schröder K, Ohl A, Schlosser M. In vivo examination of the inflammatory response against allylamine plasma polymer coated titanium implants in a rat model. Acta Biomater. 2010;6:676-83.
26. Marfaing-Koka A, Maravic M, Humbert M, Galanaud P, Emilie D. Contrasting effects of IL-4, IL-10 and corticosteroids on RANTES production by human monocytes. Int Immunol. 1996;8:1587-94. (Pubitemid 26341099)
27. Terres G, Coffman RL. The role of IL-4 and IL-10 cytokines in controlling an anti-tumor response in vivo. Int Immunol. 1998;10:823-32. (Pubitemid 28279486)
28. Specht S, Volkmann L, Wynn T, Hoerauf A. Interleukin-10 (IL-10) counterregulates IL-4-dependent effector mechanisms in Murine Filariasis. Infect Immun. 2004;72:6287-93. (Pubitemid 39425406)
29. Baldwin L, Hunt JA. Host inflammatory response to NiCr, CoCr and Ti in a soft tissue implantation model. J Biomed Mater Res A. 2006;79:574-81. (Pubitemid 44845171)
30. Wang JY, Wicklund BH, Gustilo RB, Tsukayama DT. Prosthetic metals impair murine immune response and cytokine release in vivo and in vitro. J Orthop Res. 1997;15:688-99. (Pubitemid 28018995)
31. Suska F, Gretzer C, Esposito M, Emanuelsson L, Wennerberg A, Tengvall P, Thomsen P. In vivo cytokine secretion and NF-kB activation around titanium and copper implants. Biomaterials. 2005;26:519-27. (Pubitemid 38969982)
32. Sauma D, Michea P, Lennon-Duménil AM, Fierro A, Morales J, Rosemblatt M, Bono MR. Interleukin-4 selectively inhibits interleukin-2 secretion by lipopolysaccharide-activated dendritic cells. Scand J Immunol. 2004;59:183-9. (Pubitemid 38253551)
33. Tanaka T, Hu-Li J, Seder RA, Fazekas de St Groth B, Paul WE. Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad Sci USA. 1993;90:5914-8. (Pubitemid 23191424)
34. Morris SC, Orekhova T, Meadows MJ, Heidorn SM, Yang J, Finkelman FD. IL-4 induces in vivo production of IFN-gamma by NK and NKT cells. J Immunol. 2006;176:5299-305.
35. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol. 1992;148:1143-8.
36. Mehrotra PT, Donnelly RP, Wong S, Kanegane H, Geremew A, Mostowski HS, Furuke K, Siegel JP, Bloom ET. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J Immunol. 1998;160:2637-44. (Pubitemid 28136713)
37. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 1993;178:1041-8. (Pubitemid 23260442)
38. Nicoletti F, Marco RD, Patti F, Nicoletti A, Leonardi C, Reggio E, Meroni P, Reggio A. The antiinflammatory cytokine interleukin- 13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells. Autoimmunity. 2000;32:265-70. (Pubitemid 32043781)
39. van der Poll T, de Waal Malefyt R, Coyle SM, Lowry SF. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J Infect Dis. 1997;175:118-22. (Pubitemid 27020832)
40. Maruszynski M, Pojda Z. Interleukin 6 (IL-6) levels in the monitoring of surgical trauma. A comparison of serum IL-6 concentrations in patients treated by cholecystectomy via laparotomy or laparoscopy. Surg Endosc. 1995;9:882-5.
41. Yanagawa H, Sone S, Takahashi Y, Haku T, Yano S, Shinohara T, Ogura T. Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer. 1995;71:1095-8.
42. Fiorito S, Magrini L, Goalard C. Pro-inflammatory and antiinflammatory circulating cytokines and periprosthetic osteolysis. J Bone Joint Surg Br. 2003;85:1202-6. (Pubitemid 37461419)
43. Brodbeck WG, Voskerician G, Ziats NP, Nakayama Y, Matsuda T, Anderson JM. In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. J Biomed Mater Res A. 2003;64:320-9. (Pubitemid 37521452)
44. Scaglione S, Cilli M, Fiorini M, Quarto R, Pennesi G. Differences in chemical composition and internal structure influence systemic host response to implants of biomaterials. Int J Artif Organs. 2011;34:422-31.
45. Caruso R, Trunfio S, Milazzo F, Campolo J, De Maria R, Colombo T, Parolini M, Cannata A, Russo C, Paino R, Frigerio M, Martinelli L, Parodi O. Early expression of pro- and antiinflammatory cytokines in left ventricular assist device recipients with multiple organ failure syndrome. ASAIO J. 2010;56:313-8.